ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,200.84
-1.08%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. MannKind Corporation (MNKD)

  7. MannKind Corporation (MNKD) Noticias

MNKD

MannKind (MNKD)

MannKind Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:MNKD
FechaHoraFuenteTítuloSímboloCompañía
01/05/202415:00GlobeNewswire Inc.MannKind Corporation to Hold 2024 First Quarter Financial Results Conference Call on May 8, 2024NASDAQ:MNKDMannKind Corporation
30/04/202405:05GlobeNewswire Inc.MannKind to Proceed With Phase 1 Nintedanib Dpi (Mnkd-201) Study for Pulmonary Fibrotic DiseasesNASDAQ:MNKDMannKind Corporation
29/04/202405:05GlobeNewswire Inc.MannKind Announces IND Clearance From U.S. FDA to Start Phase 3 Study of Clofazimine Inhalation Suspension for Nontuberculous Mycobacterial (NTM) Lung DiseaseNASDAQ:MNKDMannKind Corporation
03/04/202405:00GlobeNewswire Inc.MannKind Repays Certain Debt ObligationsNASDAQ:MNKDMannKind Corporation
26/03/202415:05GlobeNewswire Inc.MannKind Announces CFO TransitionNASDAQ:MNKDMannKind Corporation
11/03/202405:05GlobeNewswire Inc.INHALE-3 Study’s Initial Meal Challenge Results Comparing Afrezza® Head-To-Head With Multiple Daily Injections (MDI) and Insulin PumpsNASDAQ:MNKDMannKind Corporation
05/03/202405:05GlobeNewswire Inc.MannKind Announces New Clinical Data From Inhale-3 Study to be Presented by Dr. Irl B. Hirsch at ATTD on March 8NASDAQ:MNKDMannKind Corporation
04/03/202412:01GlobeNewswire Inc.MannKind Corporation Announces Participation at Upcoming ConferencesNASDAQ:MNKDMannKind Corporation
27/02/202415:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNKDMannKind Corporation
27/02/202415:00GlobeNewswire Inc.MannKind Corporation Reports 2023 Fourth Quarter and Full Year Financial Results: Provides Clinical Development UpdateNASDAQ:MNKDMannKind Corporation
20/02/202405:00GlobeNewswire Inc.MannKind Corporation to Hold 2023 Fourth Quarter and Full Year Financial Results Conference Call on February 27, 2024NASDAQ:MNKDMannKind Corporation
15/02/202405:05GlobeNewswire Inc.MannKind Announces Enrollment Goal Completion of INHALE-1 Pediatric Diabetes Trial Utilizing Afrezza®NASDAQ:MNKDMannKind Corporation
05/02/202405:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
02/01/202405:05GlobeNewswire Inc.MannKind and Sagard Healthcare Enter Into Royalty Purchase Agreement for Up to $200 MillionNASDAQ:MNKDMannKind Corporation
28/12/202305:00GlobeNewswire Inc.MannKind Corporation to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:MNKDMannKind Corporation
15/12/202315:09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MNKDMannKind Corporation
07/11/202315:00GlobeNewswire Inc.MannKind Corporation Reports 2023 Third Quarter Financial ResultsNASDAQ:MNKDMannKind Corporation
06/11/202305:15GlobeNewswire Inc.MannKind Announces Completion of Enrollment in U.S. Phase 4 Inhale-3 Clinical Trial in Patients Living With Type 1 DiabetesNASDAQ:MNKDMannKind Corporation
31/10/202315:00GlobeNewswire Inc.MannKind Corporation to Hold 2023 Third Quarter Financial Results Conference Call on November 7, 2023NASDAQ:MNKDMannKind Corporation
30/10/202305:15GlobeNewswire Inc.MannKind Expands Patent Portfolio With New Clofazimine Formulation PatentNASDAQ:MNKDMannKind Corporation
03/10/202320:00Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:MNKDMannKind Corporation
23/08/202315:52Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MNKDMannKind Corporation
07/08/202315:00GlobeNewswire Inc.MannKind Corporation Reports 2023 Second Quarter Financial ResultsNASDAQ:MNKDMannKind Corporation
01/08/202305:00GlobeNewswire Inc.MannKind Corporation Announces Participation in the 2023 Wedbush PacGrow Healthcare ConferenceNASDAQ:MNKDMannKind Corporation
31/07/202315:00GlobeNewswire Inc.MannKind Corporation to Hold 2023 Second Quarter Financial Results Conference Call on August 7, 2023NASDAQ:MNKDMannKind Corporation
22/06/202305:05GlobeNewswire Inc.MannKind Launches Inhale-3 Study to Address the Most Important Unmet Need Today in Adults Living With Type 1 Diabetes (T1D)NASDAQ:MNKDMannKind Corporation
11/06/202307:05GlobeNewswire Inc.Governor Ned Lamont to Tour MannKind June 12 as It Reaches a Manufacturing MilestoneNASDAQ:MNKDMannKind Corporation
30/05/202315:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MNKDMannKind Corporation
26/05/202316:59Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:MNKDMannKind Corporation
24/05/202307:30GlobeNewswire Inc.Dr. Burkhard Blank Joins MannKind as Executive Vice President of Research & Development and Chief Medical OfficerNASDAQ:MNKDMannKind Corporation
 Showing the most relevant articles for your search:NASDAQ:MNKD

Su Consulta Reciente

AMEX
XLV
Health Care Select Sector
NYSE
MCD
McDonalds
FX
EURMXN
Euro vs MXN
NASDAQ
QQQ
Invesco QQQ Trust Series 1
COIN
SOLUSD
Solana
AMEX
SPY
SPDR S&P 500
COIN
BTCUSD
Bitcoin
USOTC
BNPQY
BNP Paribas (QX)
NYSE
MRK
Merck
PM
XAUUSD
Gold vs US Dollar
NASDAQ
NVDA
NVIDIA
NASDAQ
MSFT
Microsoft
COIN
ETHUSD
Ethereum
USOTC
ADDYY
Adidas (QX)
CCOM
SILVER
SILVER
USI
USTECH100
US Tech 100
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados